Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 70 years old
- People who had an allergic reaction during surgery at any point in the last 10 years, regardless of how severe it was, what caused it, or what type of anaesthetic was used
- People who have already attended a combined allergy and anaesthesia specialist appointment at the trial centre
- (For one group of participants) People whose allergy skin tests showed a positive reaction to one of the suspected substances — either a muscle relaxant drug or an antibiotic — during their allergy consultation
- (For the other group of participants) People whose blood tests — taken at the time of the allergic reaction or at a specialist consultation — detected a specific type of antibody (called IgG) directed against one of the suspected substances, which may include a muscle relaxant, antibiotic, or antiseptic
Who may not be able to join:
- People who have not provided written consent to take part
- People who are legally under guardianship or a similar form of legal protection
- People who do not have social security coverage
- People who are pregnant or breastfeeding
- People currently receiving treatment that suppresses the immune system, or currently undergoing chemotherapy
- People with active, serious heart failure
- People already taking part in another interventional research study that has an exclusion period
- (For one group) People taking blood-thinning medications, whether by mouth or injection
- (For one group) People taking two different antiplatelet (blood-clotting-reducing) medications at the same time
- (For one group) People who have previously had a sternotomy (surgery where the breastbone is cut open)
- (For one group) People who have previously had radiation therapy to the chest area
- (For one group) People with a known allergy to local anaesthetic agents or iodine-based skin products
- (For one group) People with a history of significant skin damage or lesions over the breastbone area
- (For one group) People whose recent blood tests (within the past 2 months) show white blood cell or platelet counts below the required levels (confirm with trial site)
- (For the other group) People who experience a significant drop in blood pressure when standing up (orthostatic hypotension)
- (For the other group) People who have donated blood in the 6 to 8 weeks before joining the trial
- (For the other group) People whose recent blood test (within the past 2 months) shows haemoglobin levels below the required level for their sex (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Aurelie Gouel, MD, PhD, Assistance Publique - Hôpitaux de Paris
Phone: 00-33-1-40-25-83-55
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Obtain sequences of gene producers (VH and VL pairs) coding for the variable part of anti-drug antibodies, thanks to the isolation of B lymphocytes of antibodies directed against the responsible molecule, from blood cells or bone marrow
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.